FDA staff's own briefing document, posted publicly ahead of the meeting as part of the docket, proposes that TB-500 (free base) and TB-500 acetate not be added to the list, citing incomplete physicochemical characterization, a lack of evidence of effectiveness for wound healing (including an in-vitro fibroblast study in which TB-500 reportedly did not induce wound healing), and insufficient nonclinical and clinical safety data
Note that most BPC-157 research so far has been conducted in animals, so its benefits aren't yet established in humans, though anecdotal user reports are encouraging
How long does BPC-157 last, whether youre talking about its presence in your bloodstream or its ensuing biological cascades
Plus, get expert support to guide you in your journeyall for one monthly price
Such is the vicious cycle of the fat type-2 diabetes patient who says I know what to do, I have the information, but Im hungry and I cannot stop eating because my appetite and cravings are out of control. But for obese people, both diabetics and non-diabetics, Semaglutide may be the answer